Table 2 Univariate and multivariate logistic regression analysis of risk factors
Risk Factors | Overall Survival (OS) | |||
|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
OR (95% CI) | P value | OR (95% CI) | P value | |
Gender | ||||
 (Female or Male) | 0.714 (0.457–1.115) | 0.139 | – | – |
Age | ||||
 (>  60 years or ≤ 60 years) | 1.015 (0.992–1.038) | 0.192 | – | – |
Tumor size (cm) | ||||
 (>  5 or ≤ 5) | 0.848 (0.538–1.337) | 0.478 | – | – |
Depth of invasion | 2.062 (0.745–5.705) | 0.164 | – | – |
 (T3–4 or T1–2) |  |  |  |  |
Lymphonodus metastasis | ||||
 (N2 or N0–1) | 2.116 (1.316–3.403) | 0.002** | 0.544 (0.166–1.777) | 0.313 |
AJCC stage | ||||
 (III orI-II) | 2.764 (1.641–4.657) | 0.000** | 4.199 (1.237–14.24) | 0.021* |
Pre-treatment LY | ||||
 (>  1.535 × 109/L or ≤ 1.535 × 109/L) | 1.474 (0.987–2.200) | 0.058 | – | – |
Pre-treatment MO | ||||
 (> 0.330 × 109/L or ≤ 0.330 × 109/L) | 1.067 (0.722–1.576) | 0.745 | – | – |
Pre-treatment NE | ||||
 (>  3.325 × 109/L or ≤ 3.325 × 109/L) | 1.585 (1.060–2.371) | 0.025* | 0.868 (0.522–1.444) | 0.586 |
Pre-treatment EO | ||||
 (> 0.090 × 109/L or ≤ 0.090 × 109/L) | 0.924 (0.618–1.382) | 0.702 | – | – |
Pre-treatment BA | ||||
 (> 0.010 × 109/L or ≤ 0.010 × 109/L) | 1.151(0.775–1.709) | 0.486 | – | – |
Pre-treatment total WBC | ||||
 (>  5.361 × 109/L or ≤ 5.361 × 109/L) | 2.023 (1.329–3.081) | 0.001** | 1.751 (1.045–2.935) | 0.033* |
Post/pre-treatment LY ratio | ||||
 (>  1 or ≤ 1) | 0.839 (0.563–1.249) | 0.387 | – | – |
Post/pre-treatment MO ratio | ||||
 (>  1 or ≤ 1) | 1.036 (0.703–1.527) | 0.860 | – | – |
Post/pre-treatment NE ratio | ||||
 (>  1 or ≤ 1) | 0.871 (0.571–1.329) | 0.521 | – | – |
Post/pre-treatment EO ratio | ||||
 (>  1 or ≤ 1) | 1.180 (0.796–1.748) | 0.410 | – | – |
Post/pre-treatment BA ratio | ||||
 (>  1 or ≤ 1) | 1.006 (0.638–1.585) | 0.980 | – | – |
Post/pre-treatment total WBC ratio | ||||
 (>  1 or ≤ 1) | 0.766 (0.508–1.154) | 0.202 | – | – |